Prevalence of intestinal parasitic infections among pregnant women in Bobo-Dioulasso (Burkina Faso).


Journal

Annals of parasitology
ISSN: 2299-0631
Titre abrégé: Ann Parasitol
Pays: Poland
ID NLM: 101593588

Informations de publication

Date de publication:
2021
Historique:
entrez: 25 12 2021
pubmed: 26 12 2021
medline: 29 12 2021
Statut: ppublish

Résumé

Pregnant women are the most vulnerable populations exposed to intestinal parasitoses. To develop strategies to fight against these infections, it is essential to carry out regular surveys in order to provide reliable epidemiological data on intestinal parasitoses in at-risk populations. A prospective cross-sectional study was carried out from February to April 2015 in pregnant women seen during the prenatal consultation. The study took place in 3 health centers located in Health District of Dafra at Bobo-Dioulasso in Burkina Faso. The parasitological examination consisted in carrying out a standard stool parasitological examination and the modified Ziehl Neelsen staining. A total of 315 stool samples were collected and analyzed. The overall prevalence of intestinal parasitosis was 66.7% [95% CI: 61.1–71.8] with prevalences of 60.9% in Bolomakot., 69.2% in Guimbi and 69.8% in Y.gu.r.sso. Protozoa were the most encountered with of 66.0% prevalence and 1.3% of helminths. The most common protozoa species were Entamoeba coli (36.2%), Giardia lamblia (16.2%), Entamoeba histolytica (14.9%), Cryptosporidium sp. (12.1%) and Trichomonas intestinalis (10.5%). The helminths were represented by Hymenolepis nana (0.6%), Strongyloides stercoralis (0.3%) and Dicrocoelium sp. (0.3%). The prevalence of intestinal parasitosis is very high in pregnant women and dominated by protozoa. Most recently, it has been shown that metronidazole can be administered at all ages of pregnancy at a dosage of 1 g/day for 5 days for the treatment of intestinal protozoa in pregnant women. It would therefore be essential to evaluate this strategy in Burkina Faso by administering metronidazole concomitantly with sulfadoxine-pyrimethamine.

Identifiants

pubmed: 34953124
doi: 10.17420/ap6703.362
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

489-497

Auteurs

Ibrahim Sangaré (I)

Institut Supérieur des Sciences de la Santé, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso
Centre Hospitalier Universitaire Souro SANOU, Bobo-Dioulasso, Burkina Faso
Institut National de Santé Publique, Centre MURAZ, Bobo-Dioulasso, Burkina Faso

Kiswendsida Thierry Guiguemdé (KT)

Unité de Formation et de Recherche en Sciences de la Santé, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso

Adama Zida (A)

Unité de Formation et de Recherche en Sciences de la Santé, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso

Constant Sirima (C)

Institut National de Santé Publique, Centre MURAZ, Bobo-Dioulasso, Burkina Faso

Patindoilba Marcel Sawadogo (PM)

Unité de Formation et de Recherche en Sciences de la Santé, Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso

Mamoudou Cissé (M)

Institut Supérieur des Sciences de la Santé, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso
Institut National de Santé Publique, Centre MURAZ, Bobo-Dioulasso, Burkina Faso

Sessinou Benoît Assogba (SB)

Disease Control and Elimination Department, Medical Research Council, Unit The Gambia at London School of Hygiene and Tropical Medicine, Gambia

Tinga Robert Guiguemdé (TR)

Institut Supérieur des Sciences de la Santé, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso
Centre Hospitalier Universitaire Souro SANOU, Bobo-Dioulasso, Burkina Faso
Institut National de Santé Publique, Centre MURAZ, Bobo-Dioulasso, Burkina Faso

Sanata Bamba (S)

Institut Supérieur des Sciences de la Santé, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso
Centre Hospitalier Universitaire Souro SANOU, Bobo-Dioulasso, Burkina Faso

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH